ZELLUNA IMMUNOTHERAPY AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−101,8 mill kr).
- Nylig endring 2026-07-31 Aksjekapital registrert 2026-07-31.
ZELLUNA IMMUNOTHERAPY AS is registered as a limited company in Oslo, Oslo with organisation number 816823862. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2016 and has 10 registered employees. Registered share capital is NOK 2.7m, divided into 13524826 shares. The company's stated purpose is: “Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −101.8m in operating profit.
Former names: TCR BIOPHARMA AS
Key figures · 2025
Financial health · 2025
Who owns ZELLUNA IMMUNOTHERAPY AS?
ZELLUNA IMMUNOTHERAPY AS has 1 registered shareholder:
- ZELLUNA ASA 100.0%
Frequently asked questions about ZELLUNA IMMUNOTHERAPY AS
Who owns ZELLUNA IMMUNOTHERAPY AS?
ZELLUNA ASA is the largest registered owner, with 100.0%.
What is the revenue of ZELLUNA IMMUNOTHERAPY AS?
ZELLUNA IMMUNOTHERAPY AS had revenue of NOK 0 in 2025.
Who is the general manager of ZELLUNA IMMUNOTHERAPY AS?
Namir Jafar Hassan is registered as general manager of ZELLUNA IMMUNOTHERAPY AS.
Where is ZELLUNA IMMUNOTHERAPY AS based?
ZELLUNA IMMUNOTHERAPY AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.